re: attn: charry3 Good to see someone else doing research. I...

re: attn: charry3 Good to see someone else doing research. I believe the unnamed japanese company is Suminmoto or Sumimoto(sorry about the spelling, something like that).

Also this from my source: As a shareholder, you will have recently received our newsletter with an update on what is happening within BioProspect, however, you have asked for specific information regarding the prostate cancer nutraceutical.



Firstly I would like to point out that BioProspect’s role with this product is purely in relation to the research and development of the product. InterHealth Biotechnologies (formerly Lane Laboratories) are responsible for the registration and marketing of this product. Currently, IHB has submitted data to the relevant regulatory authority for its final ratification and they have been awaiting clearance on this product to allow IHB to launch and market the product in the USA. The submission has been with the regulatory body for over six months and BioProspect and IHB are in their hands in regards to their processing of the submission. Until we have formal notification from IHB and the regulators, it is inappropriate for us to release information on the launch date for this particular product.

Good luck to holders - buy in when others sell out don't panic.